Canaccord Genuity Group restated their hold rating on shares of Lilium (NASDAQ:LILM – Free Report) in a research report report published on Thursday, Benzinga reports. The brokerage currently has a $0.70 target price on the stock, down from their prior target price of $1.85.
Separately, Cantor Fitzgerald reiterated an “overweight” rating and set a $2.00 price target on shares of Lilium in a report on Monday, September 30th.
Get Our Latest Report on Lilium
Lilium Stock Down 21.3 %
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. XTX Topco Ltd acquired a new position in Lilium during the 2nd quarter worth approximately $25,000. Warberg Asset Management LLC acquired a new position in shares of Lilium in the 2nd quarter valued at $27,000. RS Crum Inc. acquired a new position in shares of Lilium in the 2nd quarter valued at $328,000. Longitude Cayman Ltd. boosted its holdings in shares of Lilium by 12.2% in the 2nd quarter. Longitude Cayman Ltd. now owns 1,514,672 shares of the company’s stock valued at $1,204,000 after buying an additional 164,672 shares in the last quarter. Finally, Financial Designs Corp acquired a new position in shares of Lilium in the 2nd quarter valued at $32,000. Institutional investors and hedge funds own 8.30% of the company’s stock.
Lilium Company Profile
Lilium N.V. engages in the research and development of electric vertical takeoff and landing aircrafts and jet for use in high-speed air transport system for people and goods. It also provides aircraft manufacturer services, including training services, maintenance operations, material management and global distribution, flight operations support, ground service equipment, and digital solutions.
Read More
- Five stocks we like better than Lilium
- How to Invest in Biotech Stocks
- Wave Life Sciences Rockets 70% on Historic RNA Editing Success
- What Investors Need to Know About Upcoming IPOs
- UPS vs. FedEx: Which Stock Delivers Better Holiday Gains?
- What is the Nasdaq? Complete Overview with History
- Insider Selling is not a Signal to Start Selling Gartner Stock
Receive News & Ratings for Lilium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lilium and related companies with MarketBeat.com's FREE daily email newsletter.